Novo Nordisk A/S (NVO): A Bull Case Theory

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S (NVO)'s share was trading at $64.49 as of April 15^th. NVO’s trailing and forward P/E were 18.76 and 15.41 respectively according to Yahoo Finance.

[caption id="attachment_1236609" align="aligncenter" width="768"] A scientist in a lab, researching for a breakthrough treatment for Alzheimer's disease, diabetes nephropathy, asthma, COPD, NASH, and Type 1 Diabetes.[/caption]

Novo Nordisk, a dominant player in the global...